Effects of Spirulina platensis supplementation on lipid profile in HIV–infected antiretroviral naïve patients in Yaounde - Cameroon: a randomized trial study

Table 3 Baseline of demographic and clinical characteristics of patients during the trial

Variables	Ctrl/Spi	Period	Patients received local balance diet	Patients received spirulina combined with a local balance diet	*p-value*
Age (Years)	87/82	T0	35.43 ± 10.04	36.01 ± 9.44	0,58
Sex (%)
Female	87/82	T0	64.5% (56)	69.8% (60)	0.06
Male	87/82	T0	35.6% (31)	25.6% (22)	0.06
BMI (kg/m ² )	87/82	T0	26.02 ± 4.97	25.29 ± 4.54	0.33
	79/80	T6	25.18 ± 6.41	25.41 ± 4.98	0.80
	66/79	T12	22.18 ± 1.07	23.26 ± 6.53	0.44
Fasting blood sugar (mg/l)	87/82	T0	115 ± 53,70	105.89 ± 25.91	0.159
	79/80	T6	105.00 ± 30.76	103.14 ± 15.93	0.65
	66/79	T12	113.77 ± 61,85	95.35 ± 9.63	<0,001
Alcohol	14/169	To	11.9%	11.9%
	10/156	T6	11.9%	5.6%
	7/145	T12	4.4%	4.4%
Smoking	5/169	To	3%	4.5%
	5/169	T6	3%	4.5%
	6/169	T12	1.4%	3%

Ctrl: Control, Spi: Spirulina group, T0: initial period, T6: Six months, T12: Twelve months, p< 0.01: Significant difference between the group.

ISSN: 1476-511X